Skip to content

Aytu Bioscience has huge potential

Aytu Bioscience Inc.(AYTU) currently trades at $1.75 and has grown by 7.43% in the past 24 hours. Aytu recently acquired Innovus Pharmaceuticals, a specialty pharmaceutical company commercializing, licensing and developing safe and effective consumer healthcare products designed to improve men and women’s health and vitality.

Advertisements

Based on this information, investorsQ rates this stock a 5 out of 10. We give it this rating because Aytu’s strategy is to continue building its portfolio of revenue-generating products, leveraging its focused commercial team and expertise to build leading brands within large therapeutic markets. The high forecast for Aytu Bioscience Inc. is $5 and the low is $4.75. Notably, the company’s market cap is $102.02 million with a 52 week high of $2.99 and a 52 week low of $0.34.

Leave a Reply

%d bloggers like this: